Skip to main content
Premium Trial:

Request an Annual Quote

Greg Richard

Interpace Diagnostics has promoted Greg Richard to the position of chief commercial officer. He previously served as senior vice president of commercial operations. Richard has worked in the healthcare business in various positions for more than 25 years, starting in sales at Aetna, and then moving to Genentech as the director of managed care. He also served as vice president of managed care for Quest Diagnostics, vice president of sales for the Northeast division of LabCorp, and worked for several privately held companies focused in various areas including specialty CROs, molecular diagnostics, and anatomic pathology services. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.